PP14 Recombinant Human Erythropoietin For Sickle Cell Disease And Brazilian Healthcare System Sustainability: Cost-Effectiveness And Budget Impact Analysis

Guardado en:

Detalles Bibliográficos
Publicado en:	International Journal of Technology Assessment in Health Care vol. 40, no. S1 (Jan 2025), p. S59
Autor principal:	Gargano, Ludmila
Otros Autores:	Lobo, Clarisse, Haliton Alves De Oliveira, Lucchetta, Rosa
Publicado:	Cambridge University Press
Materias:	Budgets Hemoglobin Blood transfusion Blood transfusions Sustainability Technology assessment Epidemiology Cost benefit analysis Sickle cell disease Effectiveness Impact analysis Cost analysis Patients Cost control Erythropoietin Decision trees Rare diseases Erythropoiesis Health technology assessment Transfusion Renal function Social
Acceso en línea:	Citation/Abstract Full Text - PDF
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Sea el primero en dejar un comentario!